Results

Alliance Pharma – positive AGM update, remains a buy

Published 32 days ago

Alliance Pharma (APH) has made an AGM update announcement, including that trading “is good and in line with the board's expectations” and that “cash flow in the business remains strong”. This is a healthy reaffirmation of our BUY tip of last month which is now well in the money.

Alliance Pharma - once again a buy

Published 70 days ago

Specialty pharmaceutical company, Alliance Pharma (APH) is a previous successful share tip for us - recommended at 31p, with gains banked at 43p in 2015. However, there has since been positive development which looks inadequately reflected in a current sub 50p offer price and, noting also the continued presence of famed investors Nigel Wray and Slater Investments as major shareholders…

Video: John Dawson, CEO of Alliance Pharma, speaks at UK Investor Show 2017

Published 75 days ago

In this video from the storming success that was the 2017 UK Investor Show, John Dawson, CEO of Alliance Pharma (APH), is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

Video: John Dawson of Alliance Pharma presents at UK Investor Show

Published 406 days ago

Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest

This Small Pharma is Expanding into the US and Asia- A Wise Move if We Quit Europe.

Published 481 days ago

Hello Share Trekkies. The health game is a good place to be for winning share seekers like us in 2016. Bio-science firms are set to reap the benefit of an ageing world population with all its attendant health problems. And even younger folk will sadly require more medical care, unless they can do something about their unhealthy diets.

Tom Winnifrith Bearcast 26 November - taking more lectures from Hanoi Jane Paul Scott

Published 581 days ago

Oh no Paul Scott is giving me health advice again. If he promises never ever to waterboard me again with online retail gross margins I might just quit smoking. Away from that I look at car crash Slater & Gordon (SGH) following up from the earlier detailed piece HERE. In a similar vein I look at NAHL (NAH). Then it is onto EKF Diagnostics (EKF), Moneyswap (SWAP), Oilex (OEX), Forte Energy (FTE), Alliance Pharma (APH), Iofina (IOF) and the Fitbug (FITB) dog. There is no mention of Jabba The Hutt today, David Lenigas must wait for Gold & Bears on Saturday for his next drubbing. And boy will it be a drubbing.

Buy Petropavlovsk at 6.47p - target price to sell within 3 years 19p

Published 620 days ago

Investment Case: As noted last month with Berkeley Energy, it is not a surprise to see eye-watering share price declines over previous years for stocks with sector: “Mining”. Shares in *Petropavlovsk plc, formerly Peter Hambro Mining, (POG) have particularly suffered – they down from more than 400p at the commencement of 2011 and more than 100p at the commencement of 2013 to a current 6.47p offer price – amidst a combination of sector-wide and company-specific challenges, the latter including a vast debt pile. However, a recent refinancing and refocusing – with production now being optimised from a cash generation point of view – now offer the promise of a decent recovery from current levels and the shares are a buy…the target price to sell is 19p within three years.

ShareProphets

About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /